Breaking News Instant updates and real-time market news.

CANF

Can-Fite BioPharma

$1.80

0.01 (0.56%)

07:01
07/17/17
07/17
07:01
07/17/17
07:01

Can-Fite BioPharma says Phase II NAFLD/NASH trial to commence enrollment

Can-Fite BioPharma said it that it successfully concluded a Clinical Investigator Meeting with the principal investigators, researchers, and doctors participating as clinical investigators in the company's Phase II trial of its drug candidate Namodenoson in the treatment of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. The Phase II multicenter, randomized, double-blinded, placebo-controlled, dose-finding study of the efficacy and safety of Namodenoson in the treatment of NAFLD/NASH will enroll approximately 60 patients with NAFLD, with or without NASH. Patients will be enrolled in three arms, including two different dosages of Namodenoson and a placebo, given via oral tablets twice daily. The study's primary endpoints will be percent change from baseline in liver triglyceride concentration measured by nuclear magnetic resonance spectroscopy and safety. The Phase II trial design is based on preclinical studies showing Namodenoson's efficacy in reducing liver fat in NASH models as compared to placebo, improving liver function, and regenerating liver cells. Can-Fite's estimated cost of the Phase II trial is under $1 million. Namodenoson supplies are ready to be administered and the costs of supply have been paid. By 2025, the addressable pharmaceutical market for NASH is estimated to reach $35-40B.

CANF Can-Fite BioPharma
$1.80

0.01 (0.56%)

10/19/16
ROTH
10/19/16
INITIATION
Target $4
ROTH
Buy
Can-Fite BioPharma reinstated with a Buy at Roth Capital
Roth Capital analyst Sa'ar Yaniv resumed coverage of Can-Fite BioPharma with a Buy rating and $4 price target, saying the company's diversified pipeline offers "multiple shots on goal" and is relatively undervalued. The analyst expects that positive data and management execution over the coming 12-24 months could present investible catalysts.
08/29/16
RODM
08/29/16
INITIATION
Target $6
RODM
Buy
Can-Fite BioPharma assumed with a Buy at Rodman & Renshaw
Rodman & Renshaw analyst Raghuram Selvaraju assumed coverage of Can-Fite BioPharma with a Buy rating and $6 price target.

TODAY'S FREE FLY STORIES

10:25
07/20/17
07/20
10:25
07/20/17
10:25
General news
U.S. leading economic index rose 0.6% to 127.8 in June »

U.S. leading economic…

C

Citi

$66.79

0.09 (0.13%)

10:25
07/20/17
07/20
10:25
07/20/17
10:25
Conference/Events
Citigroup to hold a conference call »

CFO Gerspach holds a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jul

  • 25

    Jul

STLD

Steel Dynamics

$37.49

0.99 (2.71%)

10:21
07/20/17
07/20
10:21
07/20/17
10:21
Hot Stocks
Breaking Hot Stocks news story on Steel Dynamics »

Steel Dynamics CEO says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jul

TSLA

Tesla

$325.26

-2.98 (-0.91%)

10:21
07/20/17
07/20
10:21
07/20/17
10:21
Hot Stocks
Citi awaits better Tesla entry point as bulls, bears both make good points »

Citi analyst Itay…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

  • 08

    Aug

  • 02

    Oct

VRTX

Vertex

$159.69

27.53 (20.83%)

10:20
07/20/17
07/20
10:20
07/20/17
10:20
Options
Large call spread in Vertex Pharm after yesterday's surge »

Large call spread in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

10:20
07/20/17
07/20
10:20
07/20/17
10:20
General news
Treasury Action: longer yields rotated lower again »

Treasury Action: longer…

STLD

Steel Dynamics

$37.49

0.99 (2.71%)

10:19
07/20/17
07/20
10:19
07/20/17
10:19
Hot Stocks
Breaking Hot Stocks news story on Steel Dynamics »

Steel Dynamics cites…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jul

TSLA

Tesla

$325.26

-2.98 (-0.91%)

, JNJ

Johnson & Johnson

$136.03

0.82 (0.61%)

10:19
07/20/17
07/20
10:19
07/20/17
10:19
Initiation
On The Fly: Top five analyst initiations »

Catch up on today's…click here.

TSLA

Tesla

$325.26

-2.98 (-0.91%)

JNJ

Johnson & Johnson

$136.03

0.82 (0.61%)

TTS

Tile Shop

$14.83

-0.175 (-1.17%)

SBPH

Spring Bank Pharmaceuticals

$14.20

-0.12 (-0.84%)

DISCA

Discovery

$27.18

1.13 (4.34%)

SNI

Scripps Networks

$76.89

9.87 (14.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

  • 08

    Aug

  • 09

    Aug

  • 09

    Aug

  • 02

    Oct

PFE

Pfizer

, RAD

Rite Aid

$2.50

-0.1322 (-5.03%)

10:19
07/20/17
07/20
10:19
07/20/17
10:19
Downgrade
On The Fly: Top five analyst downgrades »

Catch up on today's…click here.

PFE

Pfizer

RAD

Rite Aid

$2.50

-0.1322 (-5.03%)

FMSA

Fairmount Santrol

$3.63

-0.245 (-6.33%)

NEWR

New Relic

$47.96

-0.84 (-1.72%)

SND

Smart Sand

$7.87

0.25 (3.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

  • 02

    Aug

  • 03

    Aug

  • 03

    Aug

  • 03

    Aug

  • 08

    Aug

  • 27

    Aug

  • 29

    Aug

NKE

Nike

$59.31

1.54 (2.67%)

, BGS

B&G Foods

$37.08

1.275 (3.56%)

10:18
07/20/17
07/20
10:18
07/20/17
10:18
Upgrade
On The Fly: Top five analyst upgrades »

Catch up on today's…click here.

NKE

Nike

$59.31

1.54 (2.67%)

BGS

B&G Foods

$37.08

1.275 (3.56%)

HPQ

HP Inc.

$18.86

0.155 (0.83%)

RCL

Royal Caribbean

$115.14

2.5775 (2.29%)

BWLD

Buffalo Wild Wings

$122.60

0.65 (0.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 16

    Aug

  • 29

    Aug

  • 11

    Sep

STLD

Steel Dynamics

$37.49

0.99 (2.71%)

10:18
07/20/17
07/20
10:18
07/20/17
10:18
Hot Stocks
Steel Dynamics sees more stabilized scrap environment in 2H »

Comments from Q2 earnings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jul

$NSD

NASDAQ Market Internals

10:17
07/20/17
07/20
10:17
07/20/17
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

10:16
07/20/17
07/20
10:16
07/20/17
10:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:15
07/20/17
07/20
10:15
07/20/17
10:15
General news
FX Action: The dollar »

FX Action: The dollar…

10:15
07/20/17
07/20
10:15
07/20/17
10:15
General news
Breaking General news story  »

Week of 7/14 EIA Natural…

RAD

Rite Aid

$2.50

-0.129 (-4.90%)

10:11
07/20/17
07/20
10:11
07/20/17
10:11
Hot Stocks
Rite Aid expands Naloxone dispensing program to Michigan, South Carolina »

Rite Aid announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHLB

Berkshire Hills Bancorp

10:10
07/20/17
07/20
10:10
07/20/17
10:10
Hot Stocks
Breaking Hot Stocks news story on Berkshire Hills Bancorp »

Berkshire Hills Bancorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jul

AMZN

Amazon.com

$1,026.87

2.42 (0.24%)

, GOOG

Alphabet

$970.89

5.49 (0.57%)

10:10
07/20/17
07/20
10:10
07/20/17
10:10
Periodicals
AWS weighs new cloud service based on popular Google software, Information says »

Amazon Web Services…

AMZN

Amazon.com

$1,026.87

2.42 (0.24%)

GOOG

Alphabet

$970.89

5.49 (0.57%)

GOOGL

Alphabet Class A

$992.77

5.82 (0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jul

  • 24

    Jul

  • 27

    Jul

TMST

TimkenSteel

$16.00

-0.18 (-1.11%)

, STLD

Steel Dynamics

$37.49

0.99 (2.71%)

10:10
07/20/17
07/20
10:10
07/20/17
10:10
Recommendations
TimkenSteel, Steel Dynamics, AK Steel, U.S. Steel, Nucor analyst commentary  »

Cowen would be buying…

TMST

TimkenSteel

$16.00

-0.18 (-1.11%)

STLD

Steel Dynamics

$37.49

0.99 (2.71%)

AKS

AK Steel

$6.52

-0.08 (-1.21%)

X

U.S. Steel

$24.11

-0.36 (-1.47%)

NUE

Nucor

$59.14

-1.52 (-2.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jul

  • 20

    Jul

  • 25

    Jul

  • 26

    Jul

  • 01

    Aug

XBI

SPDR S&P BIOTECH

$79.80

0.69 (0.87%)

10:10
07/20/17
07/20
10:10
07/20/17
10:10
Options
Defensive option play in the SPDR Biotech ETF »

Defensive option play in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHLB

Berkshire Hills Bancorp

$36.60

0.1 (0.27%)

10:09
07/20/17
07/20
10:09
07/20/17
10:09
Earnings
Berkshire Hills Bancorp sees Q3 core EPS 58c, consensus 57c »

Sees total annualized…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jul

IRWD

Ironwood

$18.55

-0.23 (-1.22%)

10:07
07/20/17
07/20
10:07
07/20/17
10:07
Recommendations
Ironwood analyst commentary  »

Ironwood weakness a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWLO

Twilio

$31.29

-0.21 (-0.67%)

10:07
07/20/17
07/20
10:07
07/20/17
10:07
Technical Analysis
Technical View: Twilio spikes higher on unconfirmed takeover rumors »

The stock was last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

  • 08

    Aug

10:07
07/20/17
07/20
10:07
07/20/17
10:07
General news
Leading Indicators data reported »

June Leading Indicators…

JD

JD.com

$43.22

0.23 (0.54%)

10:05
07/20/17
07/20
10:05
07/20/17
10:05
Options
JD.com call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.